This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Civilmart's proposal to acquire Taylex to be reviewed in Australia

( February 26, 2026, 06:11 GMT | Official Statement) -- MLex Summary: The proposal by CTC Precast, trading as Civilmart, to acquire 100 percent of the issued share capital in Taylex Group Holding will be reviewed by Australia’s antitrust watchdog. In a statement on Thursday, the Australian Competition & Consumer Commission said Civilmart is owned by CRH Infrastructure Products Australia, which in turn is owned by CRH plc, a global supplier of building materials and infrastructure products. The statement said Taylex, through its wholly owned subsidiaries, manufactures and supplies active wastewater-treatment systems, septic tanks and rainwater tanks in Australia. The regulator added that both Civilmart and Taylex supply concrete active wastewater-treatment systems and associated products across Australian states including New South Wales, Queensland and Victoria.Statement follows. Questionnaire is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections